Trials / Conditions / Constipation-predominant Irritable Bowel Syndrome

Constipation-predominant Irritable Bowel Syndrome

24 registered clinical trials studyying Constipation-predominant Irritable Bowel Syndrome — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	"Efficacy and Safety of Linaclotide in Chronic Constipation" NCT07431957	Md Mehedi Shahriar	Phase 4
Not Yet Recruiting	Soluble and Osmotic Fibre (SOLOS) Diet for Constipation NCT07388589	Singapore Institute of Technology	—
Unknown	To Study the Effect of Short-chain Fructooligosaccharides in Women With Irritable Bowel Syndrome NCT05941650	Universidad Autonoma de Chihuahua	N/A
Completed	MOWOOT Device Treatment for Adults With Chronic Constipation NCT04666155	usMIMA S.L.	N/A
Unknown	A Chinese Herbal Medicine for IBS-C NCT06319729	Hong Kong Baptist University	Phase 2
Unknown	Anorectal Manometry of Patients With Constipation Predominant IBS NCT05921383	Assiut University	—
Unknown	Laser Acupuncture on Irritable Bowel Syndrome in Females NCT05757037	Cairo University	N/A
Withdrawn	The Impact of Aerobic Interval and Inspiratory Muscle Training On Patient Reported Outcome Scores In Individua NCT05321953	University of Miami	N/A
Completed	Safety and Efficacy of Non-alcoholic Beverage Based on Kombucha in Patients With Constipations NCT05164861	Vasily Isakov	N/A
Unknown	Efficacy of Linaclotide in Patients With Overlapping Functional Gastrointestinal Disorders NCT05134584	RenJi Hospital	Phase 4
Completed	Effect of taVNS on Abdominal Pain and Other Symptoms in Constipation-predominant Irritable Bowel Syndrome NCT05392439	Tongji University	N/A
Terminated	Assessment of Responsiveness to Treatment by Experience Sampling Method NCT03336034	Maastricht University Medical Center	—
Completed	Effect of Saccharomyces Cerevisiae on the Improvement of Gastro-intestinal Disorders Associated to IBS With C NCT03150212	Lesaffre International	N/A
Completed	A Long-Term Safety Study of Tenapanor for the Treatment of IBS-C NCT02727751	Ardelyx	Phase 3
Completed	A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C NCT02686138	Ardelyx	Phase 3
Completed	A 12-Week Study With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Tenapanor fo NCT02621892	Ardelyx	Phase 3
Completed	The Efficacy of AZD1722 in Constipation Predominant Irritable Bowel Syndrome (IBS-C) NCT01923428	Ardelyx	Phase 2 / Phase 3
Completed	A Study to Evaluate the Safety and Efficacy of RDX5791 for the Treatment of Constipation Predominant Irritable NCT01340053	Ardelyx	Phase 2
Completed	Effect of Lubiprostone on Small Bowel Contractions in Female Patients With Constipation Irritable Bowel Syndro NCT01085643	Cedars-Sinai Medical Center	N/A
Completed	Neomycin and Rifaximin Plus Neomycin in Treating Methane Positive Constipation Predominant Irritable Bowel Syn NCT00945334	Mark Pimentel, MD	N/A
Completed	Cheno Effect on Transit in Health and IBS-C NCT00912301	Mayo Clinic	Phase 2
Terminated	Randomized Trial of Mosapride Versus Placebo in the Treatment of Constipation-Predominant Irritable Bowel Synd NCT00742872	American University of Beirut Medical Center	Phase 3
Terminated	Long-Term Safety of Renzapride in Women With Constipation-Predominant Irritable Bowel Syndrome (IBS-C) NCT00607971	Alizyme	Phase 3